Wortmannin alters the transferrin receptor endocytic pathway in vivo and in vitro - PubMed (original) (raw)

Wortmannin alters the transferrin receptor endocytic pathway in vivo and in vitro

D J Spiro et al. Mol Biol Cell. 1996 Mar.

Free PMC article

Abstract

Treatment with the phosphatidylinositol 3-kinase inhibitor wortmannin promotes approximately 30% decrease in the steady-state number of cell-surface transferrin receptors. This effect is rapid and dose dependent, with maximal down-regulation elicited with 30 min of treatment and with an IC50 approximately 25 nM wortmannin. Wortmannin-treated cells display an increased endocytic rate constant for transferrin internalization and decreased exocytic rate constants for transferrin recycling. In addition to these effects in vivo, wortmannin is a potent inhibitor (IC50 approximately 15 nM) of a cell-free assay that detects the delivery of endocytosed probes into a common compartment. Inhibition of the in vitro assay involves the inactivation of a membrane-associated factor that can be recruited onto the surface of vesicles from the cytosol. Its effects on the cell-free assay suggest that wortmannin inhibits receptor sorting and/or vesicle budding required for delivery of endocytosed material to "mixing" endosomes. This idea is consistent with morphological changes induced by wortmannin, which include the formation of enlarged transferrin-containing structures and the disruption of the perinuclear endosomal compartment. However, the differential effects of wortmannin, specifically increased transferrin receptor internalization and inhibition of receptor recycling, implicate a role for phosphatidylinositol 3-kinase activity in multiple sorting events in the transferrin receptor's membrane traffic pathway.

PubMed Disclaimer

Cited by

Hydroxyl-Rich Hydrophilic Endocytosis-Promoting Peptide with No Positive Charge.
Wang S, Li Z, Aispuro D, Guevara N, Van Valkenburgh J, Chen B, Zhou X, McCarroll MN, Ji F, Cong X, Sarkar P, Chaudhuri R, Guo Z, Perkins NP, Shao S, Sello JK, Chen K, Xue M. Wang S, et al. J Am Chem Soc. 2022 Nov 9;144(44):20288-20297. doi: 10.1021/jacs.2c07420. Epub 2022 Oct 27. J Am Chem Soc. 2022. PMID: 36301712 Free PMC article.
TLR2 axis on peripheral blood mononuclear cells regulates inflammatory responses to non-infectious immature dengue virus particles.
Aguilar Briseño JA, Ramos Pereira L, van der Laan M, Pauzuolis M, Ter Ellen BM, Upasani V, Moser J, de Souza Ferreira LC, Smit JM, Rodenhuis-Zybert IA. Aguilar Briseño JA, et al. PLoS Pathog. 2022 Oct 14;18(10):e1010499. doi: 10.1371/journal.ppat.1010499. eCollection 2022 Oct. PLoS Pathog. 2022. PMID: 36240261 Free PMC article.
De Novo Design of A Membrane-Anchored Probe for Multidimensional Quantification of Endocytic Dynamics.
Qiu K, Seino R, Han G, Ishiyama M, Ueno Y, Tian Z, Sun Y, Diao J. Qiu K, et al. Adv Healthc Mater. 2022 Apr;11(8):e2102185. doi: 10.1002/adhm.202102185. Epub 2022 Jan 27. Adv Healthc Mater. 2022. PMID: 35032365 Free PMC article.
SialoPen peptides are new cationic foldamers with remarkable cell permeability.
Monreal IA, Contreras EM, Wayman GA, Aguilar HC, Saludes JP. Monreal IA, et al. Heliyon. 2020 Dec 24;6(12):e05780. doi: 10.1016/j.heliyon.2020.e05780. eCollection 2020 Dec. Heliyon. 2020. PMID: 33409387 Free PMC article.
Pathological missorting of endogenous MAPT/Tau in neurons caused by failure of protein degradation systems.
Balaji V, Kaniyappan S, Mandelkow E, Wang Y, Mandelkow EM. Balaji V, et al. Autophagy. 2018;14(12):2139-2154. doi: 10.1080/15548627.2018.1509607. Epub 2018 Sep 13. Autophagy. 2018. PMID: 30145931 Free PMC article.

References

1. J Biol Chem. 1994 Feb 4;269(5):3568-73 - PubMed
1. J Biol Chem. 1994 Dec 16;269(50):31552-62 - PubMed
1. Science. 1995 Aug 4;269(5224):690-3 - PubMed
1. J Cell Biol. 1995 Aug;130(4):781-96 - PubMed
1. Cell. 1992 Apr 3;69(1):129-38 - PubMed

Wortmannin alters the transferrin receptor endocytic pathway in vivo and in vitro - PubMed (original) (raw)